Citi Just Upgraded UiPath Stock. Here's Why.

UiPath (PATH) stock rose 7.53% to $14.78 after Gartner named it a Leader in Intelligent Document Processing for the second year. The recognition highlights UiPath's role in enterprise automation and document management, with its IXP platform converting complex documents into structured data for workflows.

C3.ai (AI) reported a -188% operating margin for Q2 2026, despite restructuring and new agreements, while UiPath (PATH) reported an 8% margin. C3.ai's revenue declined, but customer bookings rose 73% QoQ. UiPath's revenue grew 13% YoY in Q2 but expects slower growth in Q3.

UiPath (NYSE:PATH) shares are down year-to-date, but Wall Street sentiment is improving. DA Davidson raised its price target to $16. Q2 revenue grew 13% YoY to $410M, with ARR up 12%. Q3 guidance is $440M-$445M. Hedge funds increased stakes, but short interest is high at 29%. Growth concerns persist due to AI competition and monetization uncertainties.

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

UiPath (PATH) reported Q2 2027 revenue of $410M, up 13% YoY, with ARR at $1.938B, growing 12%. Non-GAAP operating income was $89M (22% margin). Cloud ARR grew 19% to $1.3B. Full-year revenue guidance is $1.789B-$1.794B. The company highlighted AI integration in deals and operational improvements, including a 60% reduction in implementation effort.

UiPath Inc. (PATH) stock fell 3.44% on September 9, 2026, extending a 27% decline since late August. The drop follows a disappointing earnings reaction, with revenue of $410.3M and net income of $36.1M for Q2 2026. Bank of America raised its price target to $15 but maintained an Underperform rating, citing cautious AI growth expectations. Insider sales and weak chart patterns add to trader skepticism.